JP2024545602A5 - - Google Patents
Info
- Publication number
- JP2024545602A5 JP2024545602A5 JP2024529302A JP2024529302A JP2024545602A5 JP 2024545602 A5 JP2024545602 A5 JP 2024545602A5 JP 2024529302 A JP2024529302 A JP 2024529302A JP 2024529302 A JP2024529302 A JP 2024529302A JP 2024545602 A5 JP2024545602 A5 JP 2024545602A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleotide
- double
- stranded oligonucleotide
- hsd17b13
- skeletal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163264360P | 2021-11-19 | 2021-11-19 | |
| US63/264,360 | 2021-11-19 | ||
| US202263268775P | 2022-03-02 | 2022-03-02 | |
| US63/268,775 | 2022-03-02 | ||
| US202263377482P | 2022-09-28 | 2022-09-28 | |
| US63/377,482 | 2022-09-28 | ||
| PCT/US2022/050371 WO2023091644A2 (en) | 2021-11-19 | 2022-11-18 | Hsd17b13-related double stranded oligonucleotide compositions and methods relating thereto |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024545602A JP2024545602A (ja) | 2024-12-10 |
| JP2024545602A5 true JP2024545602A5 (enExample) | 2025-11-27 |
Family
ID=86397758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024529302A Pending JP2024545602A (ja) | 2021-11-19 | 2022-11-18 | Ｈｓｄ１７ｂ１３関連二本鎖オリゴヌクレオチド組成物及びそれに関連する方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240384273A1 (enExample) |
| EP (1) | EP4433596A4 (enExample) |
| JP (1) | JP2024545602A (enExample) |
| WO (1) | WO2023091644A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR20210395A (es) | 2018-12-21 | 2021-11-05 | Ionis Pharmaceuticals Inc | Moduladores de la expresión de hsd17b13 |
| US20240352464A1 (en) * | 2023-03-07 | 2024-10-24 | Aligos Therapeutics, Inc. | Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses Thereof |
| WO2024255748A1 (zh) * | 2023-06-16 | 2024-12-19 | 施能康医药科技(苏州)有限公司 | 靶向17-β-羟基类固醇脱氢酶13的核酸及其用途 |
| WO2025184661A1 (en) * | 2024-03-01 | 2025-09-04 | Wave Life Sciences Ltd. | Double stranded oligonucleotide compositions and methods relating thereto |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112016016400A2 (pt) * | 2014-01-16 | 2017-10-03 | Wave Life Sciences Ltd | Composições de oligonucleotídeos quiralmente controlados, seu uso, sua composição farmacêutica, e métodos |
| RU2019126483A (ru) * | 2017-01-23 | 2021-02-24 | Ридженерон Фармасьютикалз, Инк. | Варианты 17-бета-гидроксистероиддегидрогеназы 13 (hsd17b13) и их применение |
| JP2020522510A (ja) * | 2017-06-02 | 2020-07-30 | ウェイブ ライフ サイエンシズ リミテッドＷａｖｅ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｌｔｄ． | オリゴヌクレオチド組成物及びその使用方法 |
| EP3728281A1 (en) * | 2017-12-21 | 2020-10-28 | Alnylam Pharmaceuticals Inc. | Chirally-enriched double-stranded rna agents |
| AU2019239971B2 (en) * | 2018-03-21 | 2025-09-11 | Regeneron Pharmaceuticals, Inc. | 17beta-hydroxysteroid dehydrogenase type 13 (HSD17b13) iRNA compositions and methods of use thereof |
| KR102769565B1 (ko) * | 2018-09-19 | 2025-02-20 | 애로우헤드 파마슈티컬스 인코포레이티드 | 17베타-HSD 유형 13- (HSD17B13)의 발현을 억제하기 위한 RNAi 작용제, 그의 조성물, 및 사용 방법 |
| CR20210395A (es) * | 2018-12-21 | 2021-11-05 | Ionis Pharmaceuticals Inc | Moduladores de la expresión de hsd17b13 |
-
2022
- 2022-11-18 EP EP22896516.6A patent/EP4433596A4/en active Pending
- 2022-11-18 WO PCT/US2022/050371 patent/WO2023091644A2/en not_active Ceased
- 2022-11-18 JP JP2024529302A patent/JP2024545602A/ja active Pending
-
2024
- 2024-05-17 US US18/667,824 patent/US20240384273A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024545602A5 (enExample) | ||
| JP2024009824A5 (enExample) | ||
| Choudhuri | Bioinformatics for beginners: genes, genomes, molecular evolution, databases and analytical tools | |
| JP2022550915A5 (enExample) | ||
| Wood et al. | Variation in the control region sequence of the sheep mitochondrial genome | |
| US7014997B2 (en) | Chromosome structural abnormality localization with single copy probes | |
| JP7054675B2 (ja) | 網膜色素変性症１８と網膜色素変性症１３の処置のための組成物と方法 | |
| JP2023548584A5 (enExample) | ||
| JP2022519019A5 (enExample) | ||
| JP2005517438A5 (enExample) | ||
| US20090312533A1 (en) | Single copy genomic hybridization probes and method of generating same | |
| JP2005517436A5 (enExample) | ||
| JP2005517433A5 (enExample) | ||
| JP2006502694A5 (enExample) | ||
| RU2015151199A (ru) | Сопряженные антисмысловые соединения и их применение | |
| JP2015518714A5 (enExample) | ||
| TW202219273A (zh) | 靶向ｒｎａ結合蛋白位點之寡核苷酸 | |
| JP2022524435A5 (enExample) | ||
| MXPA04008373A (es) | Metodo para reduccion de errores en poblaciones de acido nucleico. | |
| JP2020518552A5 (enExample) | ||
| JP2024527584A5 (enExample) | ||
| JP2021511072A5 (enExample) | ||
| WO2022091100A1 (en) | Polynucleotides for rna editing and methods of using same | |
| JP2024544067A5 (enExample) | ||
| JP2023536994A5 (enExample) |